Results 1 - 10 of 335 : 1 2 3 4 5 6 7 8 9 Next
Read on to see if you have what it takes to beat the market.
This bullish call comes from more than just one analyst.
Biotech may combine the benefits of a health care boom with a defensive stock play.
The bigger they are, the harder they (might) fall.
A Potentially Painless PDUFA Date
King Pharmaceuticals and Pain Therapeutics get an appointment with the FDA.
Revenue is up, but so are expenses.
Never underestimate the importance of a moat.
Like the smart hedge fund operators, these CAPS investors have bet against a stock -- and won big!
Comparing Berkshire Hathaway to mutual funds and ETFs is problematic.
If you're out of the market on the wrong days, you're out of luck.